Clinical Trial Update: Non-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia

View source ↗

Summary

An observational non-interventional study in Russia evaluating outcomes for patients with plexiform neurofibromatosis type 1 starting selumetinib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibroma
• Neurofibromatosis Type
• Plexiform Neurofibromatosis Type

Drugs mentioned

• Koselugo (selumetinib)

Snippet

Sponsor: AstraZeneca | Conditions: Neurofibroma | Status: ACTIVE_NOT_RECRUITING